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Accuracy of a Low Priced
Liquid-Based Method for Cervical
Cytology in 632 Women Referred
for Colposcopy After a Positive
Pap Smear
B. M. van Hemel, M.D.,1* H. J. Buikema, I.A.C.,1 H. Groen, Ph.D.,2
and A. J. H. Suurmeijer, M.D., Ph.D.1
The aim of this quality controlling study was to determine the
accuracy of liquid-based cytology (LBC) with the Turbitec1
cytocentrifuge technique. Cervical smears of 632 women, who
were referred to our CIN outpatient department, after at least
two smears with ASCUS or higher were evaluated and compared
with the histological outcome. In 592 cases the smears revealed
abnormalities of squamous epithelium, and in 40 cases the
abnormalities of glandular epithelium. In the group of squamous
epithelium abnormalities, the sensitivity for LSIL was 39.7% and
the specificity was 89.2%; for the LSIL+ group, these values
were 89.4% and 91.4%, respectively. For HSIL the sensitivity
was 68.3% and the specificity 92.8%, for the HSIL+ group
82.3% and 92.3%, respectively. The ASCUS rate was low
(2.4%). The Turbitec cytocentrifuge method was proved to be a
very good LBC method for cervical smears. Because of a com-
parable accuracy together with a lower price, this LBC method
outweighs commercial alternatives. Diagn. Cytopathol. 2009;37:
579–583. ' 2009 Wiley-Liss, Inc.
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Liquid-based cytology (LBC) methods of preparation of
cell suspensions have been introduced to improve the
quality of cellular morphology and cytodiagnosis. Several
methods are now commercially available, of which the
FDA-approved ThinPrep method is used worldwide on a
large scale for population screening. A major disadvant-
age of ThinPrep is its price. It is known that the average
cost for cervical screening associated with ThinPrep is
much higher than with a conventional cervical smear.1,2
In 1999, the direct additional disposable cost was esti-
mated $9.75.3 A recent cost minimization analysis carried
out in England showed that the most optimal lowest total
processing cost per slide would be £3.68 ($5.64).4 Low-
cost LBC methods have been described. One of these
alternative monolayer slide preparation methods makes
use of a cytocentrifuge and an alcoholic-agar solution,
named 3MLBC.5–7 Other known systems in Europe using
the Hettich cytocentrifuge are CytoSCREEN1 (Seroa,
Monaco, France) and Turbitec1 (Labonord, Templemars,
France). In this quality control study, we determined the
sensitivity and specificity of LBC with the Turbitec cyto-
centrifuge technique in a series of 632 women who
recently had an abnormal cervical smear and were
referred to our CIN outpatient clinic. These women had
either smears with ASCUS, LSIL, HSIL, squamous cell
carcinoma (n ¼ 592) or a glandular epithelial lesion (n ¼
40). In all cases, histological follow-up was available to
determine the accuracy of this LBC method.
Materials and Methods
Cervical cytological smears of 655 women visiting the
CIN outpatient clinic of the Department of Gynecology of
the University Medical Center Groningen between 2000
and 2007 were included to analyze the accuracy of the
Turbitec cytocentrifuge LBC method. This group con-
sisted of women referred after a positive cervical smear
of at least two ASCUS-scores. These cytological samples
were primarily obtained for a study of the role of tumor
suppressor gene hypermethylation in cervical dysplasia
and cancer.8 As part of that study this LBC method was
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applied to determine the presence and classification of
abnormal cells according to the Bethesda classification.9
The study was approved by the medical ethics committee
of the University Medical Center Groningen.
In brief, the liquid-based Turbitec monolayer technique
applied has the following technical steps: cervical cells
obtained with a cytobrush are rinsed directly into a vial
fixation solution of 50% ethanol with 7% polyethylene
glycol 300. This solution is vortexed and cell density of
the cell suspension is measured with a photoelectric ana-
lyzer (Labonord, Templemars, France). Depending on the
cellularity of the sample, up to 6 ml of cell suspension is
transferred to a 8 ml Hettich chamber already filled with
two drops of an adhesive albumin solution (Stick-on,
Labonord, Templemars, France) in 1.5 ml ethanol-poly-
ethylene glycol 300. A cell sediment is obtained using a
Hettich cytocentrifuge (Andreas Hettich, Tuttlingen, Ger-
many) at 1,000 rpm for 10 minutes. For this purpose, a
cytoinsert with a filter card and a microscopic glass slide
already coated with 0.01% poly-L-lysine are used to
obtain a slide with a cellular monolayer with a diameter
of 17.5 mm. The slides are dried on top for 15 minutes in
the Hettich cytocentrifuge and air-dried for 5 minutes.
Cervical cells are stained with a modified Papanicolaou
stain.
Biopsies (large loop excision specimens of the cervix)
and hysterectomy specimens were fixed in 4% neutral-
buffered formalin and sectioned for light microscopy. His-
tological sections were stained with hematoxylin-eosin
(H&E).
Eighteen Turbitec specimens were excluded from the
study because of low cell count, and five specimens were
excluded because of inadequate histological sampling,
resulting in an inadequacy rate of 4.0%.
The remaining 632 specimens were included for deter-
mination of the sensitivity and specificity of Turbitec
LBC. Cervical cytological abnormalities were scored by
two experienced and LBC trained (CT/IAC) cytotechni-
cians and cytopathologists according to the Bethesda sys-
tem. In case of discrepancy, a third experienced cytotech-
nician scored the smear. These slides were scored in a
research setting, not mixed with daily normal cervical
population screening practice. The screeners were aware
that most of the slides belonged to a population of women
with a positive pap smear, but did not know which partic-
ular ones, as these were randomly mixed with slides from
women who had undergone a hysterectomy for either
uterine prolaps or leiomyoma. The cytological results
were correlated with histology of subsequent biopsies
(large loop excisions) or hysterectomies. The histological
diagnosis of the presumed cervical lesion was considered
the gold standard.
In 52 cases with discrepancies between cytodiagnosis
and histological follow-up diagnosis, smears were reeval-
uated to find out whether this discrepancy was due to
either technical shortcomings or due to diagnostic errors
made by the cytotechnicians or cytopathologists. These
discrepancies were normal cytology with a histology of
either CIN I (24 cases), CIN II-III (9 cases), or invasive
carcinoma (4 cases), and, in addition, normal histology
with cytology scored as LSIL (11 cases) or HSIL
(4 cases).
Cytology and histology outcomes were arranged in con-
tingency tables. Sensitivity and specificity were calculated
for cervical squamous cell lesions. Rates of diagnostic
agreement were analyzed by v2 and McNemar tests with
SPSS software version 14.
Results
The slides were characterized by a high-quality morphol-
ogy. Dysplastic and malignant cells were well preserved.
Cellular material was evenly distributed on the slide and
lacked drying artifact. Erythrocytes were lost due to
erythrolysis, whereas neutrophilic granulocytes were
loosely arranged instead of lying in thick streaks. As a
result, atypical, dysplastic, and malignant cells were easy
recognizable. Microbiopsies were present and in invasive
carcinomas a tumour diathesis reflected by necrotic back-
ground was well preserved, which is in contrast with
commercial available LBC methods where it is most often
lost. Because of the optimal fixation with a solution of
50% ethanol with 7% polyethylene glycol, 300 nuclear
features and chromatin pattern were excellently preserved
both for squamous and glandular neoplasms. In addition,
infections like Candida and Trichomonas were easy to
recognize.
Cytological examination of the 632 smears revealed
abnormalities of the squamous epithelium in 592 cases
and abnormalities of the glandular epithelium in 40 cases.
All lesions represented primary cervical epithelial lesions;
none of the cases represented metastatic lesions.
Squamous Lesions
Cytological diagnoses were correlated with histological
outcome translating the Bethesda terminology to the CIN
terminology, LSIL corresponding to CIN I, and HSIL cor-
responding to CIN II and CIN III. Table I summarizes the
correlation of cytological and histological diagnoses for
squamous lesions. Histology identified 131 squamous cell
carcinomas, of which 112 were also diagnosed by cytol-
ogy. Eight were underestimated as HSIL, seven as LSIL,
and four as within normal limits (WNL). Histology identi-
fied 202 CIN II-III lesions, 138 of which were also diag-
nosed by cytology, 16 were overrated as squamous cell
carcinoma, 37 underestimated as LSIL, two as ASCUS,
and nine as WNL. Histology identified 73 CIN I lesions,
29 of which were the same as the cytology outcome. Six-
teen were overvalued as HSIL, four were underestimated
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as ASCUS, and 24 as WNL. Histology identified seven as
only atypia, four of which were correctly diagnosed by
cytology. One was overrated as LSIL and two were
underestimated as WNL. Histology identified 179 speci-
mens as WNL, of which four were overscored as HSIL,
11 as LSIL, and four as ASCUS. The overall histology–
cytology correlation rate was 74.8%. The proportions of
observations in the different columns show that diagnosis
that define the table were significantly related (X2 ¼
905.988 with 16 df, P < 0.000). The sensitivity for LSIL
was 39.7% (95% CI: 28.5–50.9%) and the specificity
89.2% (95% CI: 86.5–91.9%), for HSIL these values
were 68.3% (95% CI: 61.9–74.7%) and 92.8% (95% CI:
90.2–95.4%), respectively. For squamous cell carcinoma
the sensitivity was 85.5% (95% CI: 79.5–91.5%) and the
specificity was 92.8% (95% CI: 94.8–98.2%). For the
LSIL+ group the sensitivity was 89.4% (95% CI: 86.4–
92.4%) and the specificity was 91.4% (95% CI: 87.4–
95.4%), for the HSIL+ group the sensitivity was 82.3%
(95% CI: 78.2–86.4%) and the specificity was 92.3%
(95% CI: 89.1–95.5%), respectively. The ASCUS rate
was 2.4%.
Rescreening the discrepancies in the group cytology no
abnormalities/histology CIN I (24 cases), eight classified
again as no abnormalities, two as ASCUS, four were now
rejected because of too low cell count, and 10 were
scored as LSIL. In the discrepant group cytology no
abnormalities/histology CIN II-III (9 cases), four were
classified again as no abnormalities, five as HSIL of
which four specimens had only a very few HSIL neoplas-
tic cells, too few to sign it out as HSIL. In the discrepant
group cytology no abnormalities/histology invasive carci-
noma (four cases), one was reclassified as malignant, one
was not properly fixed and should have been rejected, and
two were now rejected because of too low cell count. In
the discrepant group histology no abnormalities/cytology
LSIL (11 cases), 10 were scored as LSIL again and one
was rejected because of too low cell count. In 2 of the 10
cases scored as LSIL again, histological follow up after 1
year showed CIN I lesions. In the discrepant group histol-
ogy no abnormalities/ cytology HSIL (four cases), rescre-
ening confirmed HSIL. One of them showed a CIN III
lesion after 1 year follow up. The results obtained after
rescreening are listed in Table II. The overall histology–
cytology correlation rate was now 78.6%. The sensitivity
for LSIL was 56.2% (95% CI: 44.5–67.9%) and the speci-
ficity was 89.5% (95% CI: 86.9–92.0%), for HSIL the
sensitivity was 70.8% (95% CI: 64.5–77.1%) and the
specificity was 92.7% (95% CI: 90.1–95.3%), respec-
tively. For squamous cell carcinoma the sensitivity was
94.2% (95% CI: 90.2–98.2%) and the specificity was
96.5% (95% CI: 94.8–98.2%). The sensitivity for the
LSIL+ group was 95.0% (95% CI: 92.9–97.1%) and
the specificity was 91.5% (95%CI: 88.1–95.9%). For the
HSIL+ group these values were 84.8% (95% CI: 81.1–
88.9%) and 94.1% (95% CI: 91.1–96.9%), respectively.
The ASCUS rate was 2.7%.
Glandular Neoplasms
Histology identified 36 adenocarcinomas, 35 of which
were endocervical adenocarcinomas and one represented
an endometroid adenocarcinoma. Cytology corresponded
in 32 cases, three were underestimated as dysplasia/AIS
and one as WNL. Histology identified four cases of ade-
nocarcinoma in situ, all of which had the same diagnosis
in cytology. The results are listed in Table III.
Discussion
Optimization of technical steps in cell collection and spec-
imen preparation may translate into increased diagnostic
accuracy of cytological diagnosis of cervical epithelial
Table I. Cytohistologic Correlations for Squamous Epithelium
Cytology
Histology
Normal Atypia CIN I CIN II–III Sq ca Total %
WNL 160 2 24 9 4 199 33.6
ASCUS 4 4 4 2 0 14 2.4
LSIL 11 1 29 37 7 85 14.4
HSIL 4 0 16 138 8 166 28.0
Sq ca 0 0 0 16 112 128 21.6
Total 179 7 73 202 131 592
% 30.2 1.2 12.3 34.1 22.1 100
WNL, within normal limits; ASCUS, atypical squamous cells of undeter-
mined significance; LSIL, low grade squamous intraepithelial lesion;
HSIL, high grade squamous intraepithelial lesion; Sq ca, squamous cell
carcinoma; CIN, cervical intraepithelial neoplasm. Diagnoses in categori-
cal agreement are in boldface. They compromise 74.8% of all cases.
Table III. Cytohistologic Correlations for Glandular Epithelium
Cytology
Histology
Dysplasia/AIS Adenocarcinoma Total %
WNL 0 1 1 2.5
Dysplasia/AIS 0 3 3 7.5
Adenocarcinoma 4 32 36 90
Total 4 36 40
% 10 90 100
Abbreviations as in Table I. AIS, adenocarcinoma in situ.




Normal Atypia CIN I CIN II–III Sq ca Total %
WNL 160 2 8 4 0 174 29.8
ASCUS 4 4 6 2 0 16 2.7
LSIL 10 1 39 37 7 94 16.1
HSIL 4 0 16 143 8 171 29.3
Sq ca 0 0 0 16 113 129 22.1
Total 178 7 69 202 128 584
% 30.5 1.2 11.8 35.5 21.9 100
Abbreviations as in Table I. Diagnoses in categorical agreement are in
boldface. They compromise 78.6% of all cases.
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precursor lesions and result in improved patient care. Con-
ventionally, epithelial cells collected by brushing the cer-
vical transformation zone are smeared directly onto glass
slides. Alternatively, cervical cells can be suspended in
collecting fixation fluids, after which a thin cell layer can
be prepared on a microscopic slide. One of these LBC
methods, the ThinPrep method (Cytyc Corporation, Box-
borough, MA), is FDA approved. ThinPrep uses a rather
expensive automatic laboratory processor for dispersion
and filtration of cells from blood, mucus, and debris, after
which dispersed cells are collected on a polycarbonate fil-
ter and transferred to a microscopic glass slide. Compared
to conventional smears, LBC specimens have several
advantages. Air drying artifacts seen in conventional
smears are not observed with LBC, because cell fixation is
rapid and optimal. Moreover, removal of blood, inflamma-
tory cells, and debris results in a clean background and
allows easy visualization of atypical, dysplastic, or malig-
nant cells. The area to be screened in an LBC specimen is
much smaller than in a conventional Pap smear, which
saves reading time. The costs of LBC methods such as
ThinPrep, however, are considerably higher than those of
conventional Pap smears. Unfortunately, the additional
costs of LBC methods like ThinPrep are too high to com-
pensate for a lower number of unsatisfactory samples with
optimal morphology or increased sensitivity of detection
of ASCUS, LSIL, and HSIL, as may be concluded from
the few high-quality evidence-based studies and a single
large randomized control study performed to date.10–12
Importantly, these evidence-based studies have revealed
that, although ASCUS/LSIL detection rates may be some-
what higher with LBC, its positive predictive value for
CIN2+ is less than that obtained with conventional cervi-
cal smears. In terms of cost-effectiveness, the additional
cost of LBC may create a problem for small cytology lab-
oratories, in particular if there is no reimbursement for
LBC in population screening. Recently, a large split sam-
ple study showed that LBC reading with the ThinPrep
imager, which selects 22 fields of interest, detected 1.3
more cases of CIN grade 2 or more severe histology per
1,000 women screened than did conventionally read
slides.13 It remains to be calculated whether the improved
reading time and positive predictive value of the ThinPrep
imager method in detecting CIN 2+ is cost-effective,
allowing funding by national screening programs. For
cytology laboratories examining relatively small numbers
of specimens LBC, application of a cytocentrifuge mono-
layer technique may prove to be an attractive alternative.
In this study, we tested the accuracy of one of these cyto-
centrifuge monolayer methods, the Turbitec cytocentrifuge
method, in 632 women referred to our colposcopy CIN
outpatient clinic after a positive cervical smear.
Using a threshold of ASCUS, the sensitivity and speci-
ficity of LBC with the Turbitec method for LSIL is
39.7% (95% CI: 28.5–50.9%) and 89.2% (95% CI: 86.5–
91.9%), for HSIL 68.3% (95% CI: 61.9–74.7%) and
92.8% (95% CI: 90.2–95.4%), respectively. For the
LSIL+ group these values were 89.4% (95% CI: 86.4–
92.4%) and 91.4% (95% CI: 87.4–95.4%) respectively,
whereas the sensitivity and specificity for the HSIL+
group was 82.3% (95% CI: 78.2–86.4%) and 92.3% (95%
CI: 89.1–95.5%). In this series of women with a previ-
ously positive cervical smear, the ASCUS rate was very
low (2.4%). After reevaluation of the 52 cases with dis-
crepancies between cytodiagnosis and histological follow-
up, sensitivities and specificities were higher, as might be
expected. For LSIL the sensitivity was 56.2% (95% CI:
44.5–67.9%) and the specificity was 89.5% (95% CI:
86.9–92.1%), for HSIL 70.8% (95% CI: 64.5–77.1%) and
92.7% (95% CI: 90.1–95.3%), respectively. For the
LSIL+ group, we found a sensitivity of 95.0% (95% CI:
92.9–97.1%) and a specificity of 91.5% (95%CI: 88.1–
95.9%) and for the HSIL+ group these values were 84.8%
(95% CI: 81.1–88.9%) and 94.1% (95% CI: 91.1–96.9%),
respectively. The ASCUS rate was 2.7%.
The figures in the glandular neoplasm group were too
low to calculate an accurate reasonable sensitivity and
specificity, but showed comparably good results.
Meta-analysis has shown that conventional Pap screen-
ing has a sensitivity of approximately 50% and specificity
at about 80%.14 The sensitivity in the present study is
much higher. This is mainly the result of the study
design. Without doubt, the fact that cytotechnicians were
aware that the majority of the slides belonged to a popu-
lation of women visiting our CIN outpatient clinic has
resulted in this very high sensitivity. In fact, it is to be
expected that the sensitivity reflects the true sensitivity of
the Turbitec technique, sampling error being responsible
for the cases not detected with this monolayer technique.
The Turbitec technique slides provide a high-quality
morphology. Atypical, dysplastic, and malignant cells are
very well preserved because of optimization of ethanol-
based fixation, lack of drying artifact, equal distribution of
the cell material, reduction of inflammation, and preserva-
tion of a tumor necrotic background in invasive carcinomas.
A disadvantage of this technique is that it is a more
labor-intensive method. Preparation of one slide costs 45
minutes in addition to the time needed to make a conven-
tional slide. Nevertheless, this method is considerably
cheaper when compared with the commercial LBC meth-
ods for cervix smears and therefore could be a good alter-
native. The cost are low because of a relatively low price
of the centrifuge (around $8,000) and funnel assemblies
(for 12 pieces around $1,500) that could be washed and
reused over and over again. The only disposable that is
necessary is the filter card (around $0.30).
In conclusion, the Turbitec cytocentrifuge technique is
a very good LBC method for cervical smears with a high
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accuracy for a relatively low price and is a good alterna-
tive for the more expensive commercial LBC methods.
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